YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Low Superoxide Dismutase and Catalase Is Associated Malondialdehyde and Ischemia Modified Albumin in Patients With Non-St Elevated Myocardial Infarction (Nstemi)

dc.authorscopusid 56007682800
dc.authorscopusid 57201153848
dc.contributor.author Aladağ, N.
dc.contributor.author Şipal, A.
dc.date.accessioned 2025-05-10T17:03:19Z
dc.date.available 2025-05-10T17:03:19Z
dc.date.issued 2021
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Aladağ N., Van Yuzuncu Yil University, Faculty of Medicine, Department of Cardiology, Van, Turkey; Şipal A., University of Health Sciences, Van Training and Research Hospital, Department of Cardiology, Van, Turkey en_US
dc.description.abstract Non-ST elevated myocardial infarction (NSTEMI) diagnosis is difficult when the electrocardiography (ECG) normal and troponin parameters are slightly higher than the normal reference range. This study aimed to assess the IMA (ischemia modified albumin), MDA (malondialdehyde), SOD (superoxide dismutase), and catalase in patients with NSTEMI. The present study included 55 patients with NSTEMI and 55 healthy subjects prospectively. IMA, MDA, SOD, and catalase levels were measured from venous blood obtained from each patient within twelve hours after the onset of symptoms. Differences between the two groups were evaluated with Student's unpaired t-test for parameters with a normal distribution. IMA (3.14 ± 0.06 vs. 1.49 ± 0.03) and MDA (3.14 ± 0.06 vs. 1.49 ± 0.03) were higher, and SOD (1.10 ± 0.03 vs. 2.31 ± 0.02) and catalase (0.54 ± 0.02) vs. 0.22 ± 0.02) were lower in NSTEMI patients than control subjects. There was a significant correlation among IMA, MDA, SOD and catalase. Our data reveal that levels of MDA and IMA were increased, and SOD and catalase levels were decreased significantly in patients with NSTEMI. Blood concentrations of oxidant and antioxidant parameters could assess the oxidative state in patients with NSTEMI. © 2021, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved. en_US
dc.identifier.doi 10.5505/ejm.2021.79577
dc.identifier.endpage 170 en_US
dc.identifier.issn 1301-0883
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-85100470508
dc.identifier.scopusquality Q4
dc.identifier.startpage 165 en_US
dc.identifier.trdizinid 407051
dc.identifier.uri https://doi.org/10.5505/ejm.2021.79577
dc.identifier.uri https://hdl.handle.net/20.500.14720/5685
dc.identifier.volume 26 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Yuzuncu Yil Universitesi Tip Fakultesi en_US
dc.relation.ispartof Eastern Journal of Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Catalase en_US
dc.subject Ischemia Modified Albumin en_US
dc.subject Malondialdehyde en_US
dc.subject Nstemi en_US
dc.subject Superoxide Dismutase en_US
dc.title Low Superoxide Dismutase and Catalase Is Associated Malondialdehyde and Ischemia Modified Albumin in Patients With Non-St Elevated Myocardial Infarction (Nstemi) en_US
dc.type Article en_US

Files